8[1]Zacharski LR.Anticoagulants in cancer treatment: malignancy as a solid phase coagulopath[J].Can cer Let, 2002,186:1-9.
9[2]Palumbo JS, Kombrinck KW,and Drew AF,et al. Fibrinogen is an important determinant of the metastatic potential of circulating tumor cells[J]. Blood, 2000,96:3302-3309.
10[3]Von Tempelhoff GF,Schonmann N,Heilmann L, et al. Prognostic role of plasmaviscosity in breast cancer[J].Clin Hemorheol Microcirc, 2002,26(1): 55-61.
